OUTCOME OF FRONTLINE TREATMENT WITH “GENERIC” IMATINIB IN ADULT PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN ALGERIAN POPULATION: A MULTICENTER STUDY. Mediterr J Hematol Infect Dis 2017, 9 (1), e2017062. https://doi.org/10.4084/mjhid.2017.062.